SCHEMBL318769

SCHEMBL318769

Clc1ccnc2c(Cl)cccc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 2/20 0.68
KDM4E B2RXH2 7/20 0.58
ALDH1A1 P00352 6/20 0.58
TDP1 Q9NUW8 5/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
CYP1A2 P05177 3/20 0.52
CYP2A6 P11509 2/20 0.52
LMNA P02545 4/20 0.52
MAPT P10636 4/20 0.52
HSP90AA1 P07900 3/20 0.52
METAP2 P50579 2/20 0.52
METAP1 P53582 2/20 0.52
BRD4 O60885 1/20 0.52
SMN1; SMN2 Q16637 5/20 0.50
HTT P42858 4/20 0.50
MMP14 P50281 3/20 0.50
CYP3A4 P08684 3/20 0.50
ALOX12 P18054 3/20 0.50
TP53 P04637 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29410781 1.00 NR4A2 (0.68) NR4A2KDM4EALDH1A1TDP1MEN1
SCHEMBL196536 0.84 KDM4E (0.70) NR4A2KDM4EALDH1A1TDP1MEN1
SCHEMBL27991176 0.82 KDM4E (0.50) NR4A2KDM4EALDH1A1TDP1MEN1
SCHEMBL317120 0.81 HTR1A (0.56) NR4A2KDM4EALDH1A1TDP1MEN1
SCHEMBL1025455 0.81 NR4A2 (0.61) NR4A2KDM4EALDH1A1TDP1MEN1
SCHEMBL2701957 0.81 KDM4E (0.72) NR4A2KDM4EALDH1A1TDP1MEN1
SCHEMBL3271557 0.81 PSMD14 (0.61) NR4A2KDM4EALDH1A1TDP1MEN1
SCHEMBL2515670 0.81 NR4A2 (0.61) NR4A2KDM4EALDH1A1TDP1MEN1
SCHEMBL21101644 0.81 NR4A2 (0.61) NR4A2KDM4EALDH1A1TDP1MEN1
SCHEMBL10009591 0.81 NR4A2 (1.00) NR4A2KDM4EALDH1A1TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107163251-B High temperature resistant poly arylidene thio-ester analog copolymer and preparation method thereof 四川大学 2019-08-09 CN claimed
CN-107163251-A High temperature resistant poly arylidene thio-ester analog copolymer and preparation method thereof 四川大学 2017-09-15 CN claimed
US-20260042737-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS IMMUNESENSOR THERAPEUTICS INC (US) 2026-02-12 US disclosed
US-12281078-B2 Quinoline cGAS antagonist compounds IMMUNESENSOR THERAPEUTICS, INC. (US) 2025-04-22 US disclosed
US-20250115579-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2025-04-10 US disclosed
US-20250034139-A1 AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY PHARMA CINQ, LLC 2025-01-30 US disclosed
US-12139483-B2 Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity PHARMA CINQ, LLC (US) 2024-11-12 US disclosed
US-12134609-B2 Quinoline cGAS antagonist compounds IMMUNESENSOR THERAPEUTICS, INC. (US) 2024-11-05 US disclosed
US-12091387-B2 Quinoline cGAS antagonist compounds IMMUNESENSOR THERAPEUTICS, INC. (US) 2024-09-17 US disclosed
US-20240092760-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2024-03-21 US disclosed
US-11873291-B2 Quinoline cGAS antagonist compounds IMMUNESENSOR THERAPEUTICS, INC. (US) 2024-01-16 US disclosed
US-5240940-A Synergistic nmixture DOWELANCO (US) 1993-08-31 US disclosed
US-5202329-A Pyrimidinyloxy(thio)quinoline derivative, and agri-horticultural fungicide comprising the derivative as active ingredient MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-13 US disclosed
US-5145843-A For plants DOWELANCO (US) 1992-09-08 US disclosed
EP-0497371-A1 Pyrimidinyloxy(thio)quinoline derivatives, preparation process of the derivative, and agri-horticultural fungicide comprising the derivative as active ingredient MITSUI TOATSU CHEMICALS, Inc. (JP) 1992-08-05 EP disclosed
EP-0326330-A2 Quinoline, quinazoline, and cinnoline fungicides DowElanco (US) 1989-08-02 EP disclosed
EP-0168812-A1 4-Amino-2-phenyl quinolines, methods and intermediates for their preparation and medicaments containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1986-01-22 EP disclosed
US-4093724-A ANALGESICS ROUSSEL UCLAF (FR) 1978-06-06 US disclosed
US-4017623-A Esters of 2-[(4-quinolyl)amino]-benzoic acids in analgesic and anti-inflammatory compositions SYNTHELABO (FR) 1977-04-12 US disclosed
US-3935229-A ANALGESIC, ANTIINFLAMMATORY SYNTHELABO (FR) 1976-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250115579-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS CGAS, GLS2, GLS NR4A2 2675/4885KDM4E 4338/4885ALDH1A1 4236/4885
US-12091387-B2 Quinoline cGAS antagonist compounds CGAS, GLS2, GLS NR4A2 2675/4885KDM4E 4338/4885ALDH1A1 4236/4885
US-20260042737-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS CGAS, SSB, NT5C2 NR4A2 616/4885KDM4E 4220/4885ALDH1A1 4186/4885
US-20240092760-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS CGAS, GLS2, GLS NR4A2 2675/4885KDM4E 4338/4885ALDH1A1 4236/4885
US-11873291-B2 Quinoline cGAS antagonist compounds CGAS, GLS2, GLS NR4A2 2675/4885KDM4E 4338/4885ALDH1A1 4236/4885
US-12134609-B2 Quinoline cGAS antagonist compounds CGAS, GLS2, GLS NR4A2 2675/4885KDM4E 4338/4885ALDH1A1 4236/4885
US-20250034139-A1 AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY AADAC, CASP1, AAAS NR4A2 1254/4885KDM4E 1059/4885ALDH1A1 2393/4885
US-12281078-B2 Quinoline cGAS antagonist compounds CGAS, GLS2, GLS NR4A2 2675/4885KDM4E 4338/4885ALDH1A1 4236/4885
US-12139483-B2 Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity NOD1, NLRP3, AADAC NR4A2 1120/4885KDM4E 1620/4885ALDH1A1 2980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.